BeiGene(BGNE)
China - BeijingBiotechnology
Focus: BeiGene is a publicly-traded Chinese biotechnology company with 10,000+ employees developing oncology and immunotherapy treatments. It operates as a mid-to-large cap biotech with global clinical development capabilities and a deep pipeline of 30+ programs.
Profile data last refreshed 5h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
10001+
Open Jobs
255+44 this month
Hot — 170 jobs added in 30d
Net +44 (170 new, 126 removed). Aggressive expansion phase.
Should You Work at BeiGene?
AI assessmentBeiGene offers solid mid-cap biotech career optionality for oncology specialists seeking global scale and emerging-market exposure, but opaque financials and early-stage pipeline depth warrant due diligence on long-term stability.
Why Work Here
- Deep oncology pipeline with 4 Phase 3 programs (zanubrutinib, tislelizumab, ociperlimab, sitravatinib) offering meaningful development and launch experience in high-need cancer indications
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
First line therapy
CLL/SLLAGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
Chronic Lymphocytic LeukemiaBGB-23339
Help build intelligence for BeiGene
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.